|
|
|
Unique
structure of UK Healthcare system means UK data is the
benchmark for longitudinal patient data - around 40 million
patient years |
|
|
|
|
|
|
Patients must
register with a GP practice so patient can be followed
through treatment pathway ‘lifetime record’ |
|
|
|
|
|
|
All practices
are computerised and GPs record secondary care information |
|
|
|
|
|
|
GPs
incentivised to record outcomes, deaths and health care
indicators for common diseases (QOF) |
|
|
|
|
|
|
The data are
collected in a non-interventional way during the routine
practice of the GP and therefore reflect ‘Real Life’ |
|
|
|
|
|
|
The data allow
rapid analyses using any study design of diseases and
prescribed medicines and treatments |
|
|
|
|
|
|
Representative
of patient population and all regions throughout the UK |
|
|
|
|
|
|
Competitively
priced with flexible licence options |
|
|
|
|
|
|
All drugs –
any drug prescribed in the UK general practice can be
studied |
|
|
|
|
|
|
Quality: it is
fully auditable, validated and quality checked - data
collected are subjected to careful and consistent quality
assurance procedures |
|
|
|
|
|
|
Instant:
Patients’ data are already collected and processed which
means that both cases and controls are immediately
available for study |
|
|
|
|
|
|
Large sample
of people in the UK, currently around 4.6% of UK population |
|
|
|
|
|
|
Confidentiality – data anonymised at source |
|
|
|
|
|
|
Potential link
to GP for further information on patient care details
through AIS |
|
|
|
|
|
|
THIN Data has
links to socio economic and environmental data by postcode |
